Verified and dedicated negative control for nucleic acid testing (NAT) assays detecting single or multiple human respiratory pathogens.
Designed to validate and monitor human sample processing, extraction, amplification, and detection as an external run control.
Human sputum-like matrix containing A549 epithelial cells (20,000 cells/mL) from human lung carcinoma.
Pre-screened negative specimen, tested free of nucleic acids from a range of respiratory pathogens.
Lyophilized monodose presentation: reconstitute before use.
Non-infectious material.
Compatible with multiple molecular platforms.
MORE RESOURCES
The latest insights, news, and research articles from our scientific team.
Measles in the Americas in 2026: strengthening laboratory diagnosis amid rising cases
Measles is once again a major public health concern across the Americas.After years of progress towards elimination, measles has made a significant co...
H. pylori stool antigen testing: when the test works, but the workflow no longer does
Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
